During the past decade, Ltd. M.Zodelava Hematology Centre conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 2 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 2 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ltd. M.Zodelava Hematology Centre" #1 sponsor was "Rhizen Pharmaceuticals SA" with 2 trials, followed by "Rigel Pharmaceuticals" with 2 trials sponsored, "Catalyst Biosciences" with 1 trials sponsored, "Celgene Corporation" with 1 trials sponsored and "Kartos Therapeutics, Inc." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

According to Clinical.Site data, the most researched conditions in "Ltd. M.Zodelava Hematology Centre" are "Warm Antibody Autoimmune Hemolytic Anemia" (2 trials), "Hematological Malignancies" (1 trials), "Hemophilia A With Inhibitor" (1 trials), "Hemophilia B With Inhibitor" (1 trials) and "Leukemia, Lymphocytic, Chronic, B-Cell" (1 trials). Many other conditions were trialed in "Ltd. M.Zodelava Hematology Centre" in a lesser frequency.

Most popular intervention types in "Ltd. M.Zodelava Hematology Centre" are "Drug" (6 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Fostamatinib disodium" (2 trials), "Placebo" (2 trials), "Tenalisib" (2 trials), "Aspirin" (1 trials) and "Coagulation Factor VIIa variant" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ltd. M.Zodelava Hematology Centre" are 6 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Ltd. M.Zodelava Hematology Centre". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 5 completed trials in Ltd. M.Zodelava Hematology Centre, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ltd. M.Zodelava Hematology Centre, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".